http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110879294-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2862c6b53a112eb62a47dd428b0dfdf |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2018-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f9fa3dfa9fc0c9863e68754142999ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01255e5891b5e1c7fbec068702912480 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85ae64da3bba7094897df8e003ede54a |
publicationDate | 2020-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-110879294-A |
titleOfInvention | Use of protein markers in products for diagnosing irritable bowel syndrome and kits for diagnosing irritable bowel syndrome |
abstract | The present disclosure relates to the use of a protein marker in a product for diagnosing irritable bowel syndrome and a kit for diagnosing irritable bowel syndrome. The present disclosure utilizes ligands to jointly detect the Thymosin β4 protein in the sample, which can effectively assist in the diagnosis of patients with irritable bowel syndrome, and is beneficial to guide the clinical medication of patients with irritable bowel syndrome, so that the patients can get the best benefit. |
priorityDate | 2018-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.